The following excerpt was taken from slide 8 of a Volpara presentation lodged 2nd September.
ARPU for VolparaEnterprise alone has been rising organically, and in FY19 was US$2.20, 37% higher than FY18. In Q1, contracts signed ranged up to an ARPU of US$7 – the aim with MRS and other products is to get to US$10 and beyond.
https://wcsecure.weblink.com.au/pdf/VHT/02142146.pdf
So we can see intention is to lift over time the average revenue per user to US$10 with the benefit of the MRS acquisition. I don’t have a break even forecast but believe the size of the opportunity makes that possible with proper execution.
- Forums
- ASX - By Stock
- VHT
- General Discussion
General Discussion, page-84
-
-
- There are more pages in this discussion • 173 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
KAI
Pilbara Minerals buys land off Kairos part of its York gold project for $20M – and a 2% royalty on any PLS gold sales
AVH
Avita boosts skin restoration product portfolio with 'dermal matrix' – a kind of next-level gauze made of fake skin